CASI - CASI Pharmaceuticals EPS misses by $0.07 misses on revenue March, 16 2020 07:07 AM CASI Pharmaceuticals Inc. CASI Pharmaceuticals (NASDAQ:CASI): FY GAAP EPS of -$0.48 misses by $0.07.More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...